BFM
BCAB icon

Boothbay Fund Management’s BioAtla BCAB Stock Holding History

Boothbay Fund Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-214
Closed -$88.2K – 2129
2022
Q4 		$88.2K Buy
+214
New +$88.8K ﹤0.01% 1823
2022
Q3 		– Sell
-250
Closed -$36K – 2244
2022
Q2 		$36K Buy
+250
New +$39.8K ﹤0.01% 2113
2021
Q4 		– Sell
-508
Closed -$748K – 1869
2021
Q3 		$748K Buy
508
+268
+112% +$522K 0.02% 894
2021
Q2 		$508K Buy
240
+49
+26% +$111K 0.02% 992
2021
Q1 		$485K Buy
+191
New +$490K 0.02% 965

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boothbay Fund Management's BCAB Position: Q1 2023 in Review

Boothbay Fund Management sold out of BioAtla (BCAB) in Q1 2023, closing a stake of 214 shares — an estimated $88.2K sold.

Boothbay Fund Management first reported a position in BCAB in Q1 2021 and held it in 5 quarters. The position peaked at $748K in Q3 2021. 79 funds tracked by Wall St. Rank hold BCAB as of Q1 2023.

  • Boothbay Fund Management reported no remaining BioAtla position as of Q1 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 214 BioAtla shares in Q1 2023, an estimated $88.2K.
  • Boothbay Fund Management first reported a position in BioAtla in Q1 2021 and held it in 5 quarters.
  • Boothbay Fund Management's BioAtla position peaked at $748K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q1 2023.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.